AMP Capital Investors’s Charles River Laboratories CRL Stock Holding History

AMP Capital Investors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,772	Closed	-$2.8M	–	382
2021 Q3	$2.8M	Sell	6,772 -776	-10%	-$322K	0.02%	671
2021 Q2	$2.79M	Buy	+7,548	New	+$2.52M	0.01%	714
2019 Q3	–	Sell	-3,411	Closed	-$478K	–	1193
2019 Q2	$478K	Hold	3,411	–	–	﹤0.01%	1000
2019 Q1	$489K	Buy	3,411 +500	+17%	+$65.7K	﹤0.01%	970
2018 Q4	$325K	Buy	+2,911	New	+$364K	﹤0.01%	1019
2018 Q3	–	Sell	-5,880	Closed	-$660K	–	1158
2018 Q2	$660K	Buy	5,880 +2,720	+86%	+$294K	﹤0.01%	949
2018 Q1	$336K	Sell	3,160 -5,507	-64%	-$594K	﹤0.01%	1057
2017 Q4	$949K	Hold	8,667	–	–	0.01%	915
2017 Q3	$936K	Buy	+8,667	New	+$890K	0.01%	891

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AMP Capital Investors's CRL Position: Q4 2021 in Review

AMP Capital Investors sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 6,772 shares — an estimated $2.8M sold.

AMP Capital Investors first reported a position in CRL in Q3 2017 and held it in 9 quarters. The position peaked at $2.8M in Q3 2021. 708 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

AMP Capital Investors reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
AMP Capital Investors sold 6,772 Charles River Laboratories shares in Q4 2021, an estimated $2.8M.
AMP Capital Investors first reported a position in Charles River Laboratories in Q3 2017 and held it in 9 quarters.
AMP Capital Investors's Charles River Laboratories position peaked at $2.8M in Q3 2021.
708 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.